Camarri E, Marcolongo R, Fici F
Int J Clin Pharmacol Biopharm. 1978 Nov;16(11):527-8.
Administration of chenodeoxycholic acid (CDCA), 200 mg/day, for 5 days to patients with primary hypertriglyceridemia reduced by 34% the serum triglycerides concentration. Reduction after CDCA is statistically significant vs. the placebo. Even after a short time of CDCA administration, the pharmacological effect is clearly evident.
对原发性高甘油三酯血症患者给予鹅去氧胆酸(CDCA),剂量为每日200毫克,持续5天,可使血清甘油三酯浓度降低34%。与安慰剂相比,服用CDCA后的降低具有统计学意义。即使在服用CDCA的短时间后,药理作用也明显可见。